期刊文献+

骨髓增生异常综合征骨髓细胞凋亡率增加的研究

Probe into the Apoptosis Rate of Bone Marrow Mononuclear Cells in Myelodysplastic Syndromes
下载PDF
导出
摘要 应用末端脱氧核糖核酸转移酶(TdT)介导的dUTP缺口末端标记技术(TUNEL)、碘化丙锭染色后流式细胞仪分析两种方法观察35例骨髓增生异常综合征(MDS)、10例正常人的凋亡率.MDS中难治性贫血(RA)、环形铁粒幼细胞性难治性贫血(RAS)、难治性贫血伴原始细胞增多(RAEB)凋亡率显著高于正常人(P<0.01),难治性贫血伴原始细胞增多-转变型(RAEB-T)凋亡率无明显增高,与正常对照组无明显差异(P>0.05).说明MDS中RA、RAS、RAEB存在凋亡过度,提示凋亡过度为MDS无效造血机制之一,病情演变至RAEB-T时转为凋亡障碍.抗凋亡疗法可试用于早期MDS. The apoptosis in bone marrow mononuclear cells of 35 patients of myelodysplastic syndromes (MDS) and 10 normal controls are evaluated separately by using TDT- mediated dUTP nick end labeling method and propidium iodine staining flow cytometric analysis. The apoptosis rate drastically rises in RA,RAS,RAEB of MDS( P 〈 0.01 ), but RAEB - T of MDS exhibits a normal apoptosis(P 〉 0.05). This study shows that RA, R.AS, RAEB of MDS has an excessive apoptosis which is one of the factors leading to ineffective hematopoiesis in MDS. When progressing to RAEB- T, the apoptosis is hindered. Therapy of anti - apoptosis can be applied to early MDS patients.
出处 《绍兴文理学院学报》 2009年第9期33-36,共4页 Journal of Shaoxing University
基金 绍兴文理学院科研项目(07LG1034)
关键词 骨髓增生异常综合征 凋亡 骨髓 myelodysplastic syndromes apoptosis bone marrow
  • 相关文献

参考文献9

  • 1Bouscary D, De Vos J, Guesnu M, et al. Fas/apo- 1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes[J]. Leukemia, 1997,11 : 839 - 845.
  • 2李大启,林果为,崔为发.骨髓增生异常综合征患者骨髓细胞凋亡的初步探讨[J].山东医药,2001,41(5):7-8. 被引量:3
  • 3Parker JE, Mufti GJ, Rasool F, et al. The role of apoptosis, proliferation and the Bcl - 2 related proteins in the myelodysplastic syndromes (MDS) and acute myeloid leukemia secondary to MDS (MDS - AML)[J]. Blood,2000,96:3932 - 3928.
  • 4Kitagawa M, Yamaguchi S, Takahashi M, et al. Localization of fas and fas ligand in bone marrow cells demonstrating myelodys - plasia[J]. Leukemia, 1998,2:486 - 492.
  • 5Raza A, Mundle S, Shetty V, et al. Novel insights into the biology of myeiodysplastic syndrome : excessive apoptosis and the role of cytokines[J]. Int J Hematol, 1996,63:265 - 278.
  • 6Boula A, Voulgare M, Giannouli S, et al. Effect of cA2 anti - tumor necrosis factor - alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes[J]. Clin Cancer Res ,2006,12(10) :3099 - 3108.
  • 7Cortelezzi A, Cattaneo C, Sarina B, et al. Efficacy of N - acetylcysteine and all - trans retinoic acid in restoring in vitro effective hemopoiesis in myelodysplastic syndromes[J]. Leuk Res, 1999,24: 129- 137.
  • 8Kim MK, Lee JL, Cho HS, et al. The hematologic response to anti - apoptotic cyto kine therapy : results of pentoxifylline, ciprofloxacin, and dexamethasone treatment for patients with myelodysplastic syndrome [J]. J Korean Med Sci, 2006,21 ( 1 ) : 40 - 45.
  • 9Moroni M, Porta C, Invemizzi R, et al. TUNEL evidence of reduced bone marrow cells apoptosis in a refractory anemia patient treated with amifostine [J]. Br J Haematol, 1999,104: 420- 425.

二级参考文献6

  • 1[1]Parker JE,Mufti GJ.Ineffective haematopoiesis and apoptosis in myelodysplastic syndromes.Br J Haematol,1998,101:220~230.
  • 2[2]Bennett JM,Catovsky D,Daniel MT,et al.Proposals for the classification of the myelodysplastic syndromes.Br Jhaematol,1982,51:189~199.
  • 3[3]Shetty V,Mundle S,Alvi S,et al.Measurement of apoptosis,proliferation and three cytokines in 46 patients with myelodysplastic syndromes.Leuk Res,1996,20:891~900.
  • 4[4]Oyake T,Ishida Y,Ito S,et al.Flow cytometric analysis of apoptotic progenitor cells in patients with myelodysplastic syndrome(MDS).Blood,1999,94(suppl 1):286.
  • 5[5]Parker JE,Fishlock KL,Mijovic A,et al.Low-risk myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro-versus anti-apoptotic bcl-2-related proteins.Br J Haematal,1998,103:1075~1082.
  • 6[6]Kitagawa M,Yamaguchi S,Takahash M,et al.Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplas-ia.Leukemia,1998,12:486~492.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部